IL-37通过TGF-β/Smad3通路抑制炎症反应来缓解败血症引起的肺损伤
Yufang Guo1,2, Feifei Deng1, Yali Jiang1,3
1Department of Critical Care Medicine, The Friendship Hospital of Ili Kazakh Autonomous Prefecture, Yili, Xinjiang, P.R. China.
Immunological investigations
|April 24, 2025
概括
干白素37 (IL-37) 减少炎症和肺损伤在败血症患者和动物模型. 这种细胞因子通过降低细胞亡和炎症通路的调节来缓解败血症引起的肺损伤.
科学领域:
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
- 关键护理医学 关键护理医学
背景情况:
- 败血症涉及不受控制的炎症和免疫功能障碍,导致肺损伤,这是一个常见的死亡原因.
- 干白素37 (IL-37) 是一种细胞因子,在炎症,感染和免疫中起着已知的作用.
研究的目的:
- 研究IL-37在败血症引起的肺损伤中的作用.
- 探索IL-37在这种情况下的潜在治疗效果.
主要方法:
- 临床研究:50名败血症引起的肺损伤患者与50名健康对照.
- 动物实验:在动物中建立了败血症诱导的肺损伤模型.
主要成果:
- 在败血症患者中观察到升高的IL-37,IL-6,PCT和CRP水平.
- 在动物模型中,IL-37的使用减弱了肺,细胞损伤和炎症标志物 (IL-6,TNF-α,PCT,CRP).
- 在IL-37下调的亡 (Caspase-3,Bax) 和TGF-β/Smad3通路分子中.
结论:
- IL-37在败血症引起的肺损伤中起着保护作用.
- TGF-β/Smad3通路涉及IL-37的抗炎和保护机制,防止败血症引起的肺损伤.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
T Cell Types and Functions
617
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
617


